Degan Lu

Running trials

• Enrolling by invitation

  Efficacy and Safety of Sintilimab Combined with Platinum-containing Double-agent Chemotherapy in First-line Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer in Elderly Patients

  NCT06883136· Source

• Recruiting

  Almonertinib Combined With Anlotinib as First-line Treatment for Advanced Non-small Cell Lung Cance

  NCT06043973· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer2 recruiting

Researchers

No researcher is linked here yet.